These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7394495)

  • 21. Adolescent vaccination: coverage achieved by ages 13-15 years, and vaccinations received as recommended during ages 11-12 years, National Health Interview Survey 1997-2003.
    McCauley MM; Stokley S; Stevenson J; Fishbein DB
    J Adolesc Health; 2008 Dec; 43(6):540-7. PubMed ID: 19027641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization policies in Canadian medical schools.
    Rowan MS; Carter AO; Walker VJ
    CMAJ; 1994 Oct; 151(7):957-61. PubMed ID: 7710492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
    Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
    Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diphtheria, pertussis, poliomyelitis, tetanus, and Haemophilus influenzae type b vaccinations and risk of eczema and recurrent wheeze in the first year of life: the KOALA Birth Cohort Study.
    Kummeling I; Thijs C; Stelma F; Huber M; van den Brandt PA; Dagnelie PC
    Pediatrics; 2007 Feb; 119(2):e367-73. PubMed ID: 17272598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination update. Diphtheria, tetanus, pertussis, mumps, rubella, measles.
    Vetter RT; Johnson GM
    Postgrad Med; 1995 Oct; 98(4):133-7, 141-2, 144-5 passim. PubMed ID: 7567714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of MMR-vaccinations and diseases on atopic sensitization and allergic symptoms in Swiss schoolchildren.
    Roost HP; Gassner M; Grize L; Wüthrich B; Sennhauser FH; Varonier HS; Zimmermann H; Braun-Fahrländer Ch;
    Pediatr Allergy Immunol; 2004 Oct; 15(5):401-7. PubMed ID: 15482514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium.
    Theeten H; Vandermeulen C; Roelants M; Hoppenbrouwers K; Depoorter AM; Van Damme P
    Acta Paediatr; 2009 Aug; 98(8):1307-12. PubMed ID: 19432835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adult immunization].
    Beytout J
    Bull Acad Natl Med; 2003; 187(8):1463-74; discussion 1474-6. PubMed ID: 15146578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Vaccination scheme in advanced chronic kidney disease].
    Barril G; Teruel JL
    Nefrologia; 2008; 28 Suppl 3():95-9. PubMed ID: 19018745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
    Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Routine immunization of infants in the Canton of Zurich].
    Vranjes N; Gyurech D; Schilling J; Gugelmann R; Steffen R
    Schweiz Med Wochenschr; 1996 Jan; 126(1-2):22-6. PubMed ID: 8571109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preventive vaccinations in dentistry].
    Rostetter C; Lübbers HT; Kruse AL; Metzler P
    Swiss Dent J; 2015; 125(2):174-5. PubMed ID: 25734399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
    Zengin E; Sarper N
    Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.